A Phase III Randomized, Placebo-Controlled Clinical Trial to Study the Safety and Efficacy of the Addition of Sitagliptin (MK-0431) in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Combination Therapy With Metformin and Pioglitazone

Authors
Category Primary study
Registry of TrialsClinical Trials Peruvian Registry
Year 2009
This article has no abstract
Epistemonikos ID: cfaf5657618f026ec0dbda7a9c259f3acc571142
First added on: Apr 16, 2025